Akero Therapeutics Inc (AKRO)
NASDAQ:AKRO
Holding AKRO?
Track your performance easily

Akero Therapeutics (AKRO) Stock Investors

460 Followers
Based on 759,782 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold AKRO
On average, investors allocate 2.72% of their portfolios to AKRO
The average holding size of this company in investors' portfolios.

Investor Sentiment

Negative
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 759,782 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding AKRO

0.6%
Last 7
Days
1.6%
Last 30
Days
Percentages indicate the change in the number of portfolios holding AKRO, out of 759,782 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

AKRO Investor Activity

Action
Any
Any
Investor Performance
Any
Any
Investor Profile
Investor Action
Transaction Date
Portfolio Allocation
Execution Price
Follow
Opened
0.00%
$28.37
Based on the activity of 14,562 investors who made their portfolios public
The table shows changes in AKRO in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

AKRO Investors Also Bought

Investor Type
Any
Any
All Investors
Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
Viking Therapeutics
5.03%
-0.09%
+1.66%
7.39B
Healthcare
JD
5.24%
+1.73%
+7.66%
65.84B
Consumer Cyclical
DraftKings
5.51%
-0.61%
-2.53%
32.95B
Consumer Cyclical
Abbott Laboratories
3.60%
-0.14%
+1.18%
199.44B
Healthcare
Bristol-Myers Squibb
3.52%
-0.11%
-0.62%
106.40B
Healthcare
Block
4.16%
-0.67%
-2.24%
42.02B
Technology
Plug Power
5.17%
-1.13%
-4.09%
1.81B
Industrials
Enphase Energy
4.96%
-1.12%
-2.49%
14.11B
Technology
Blink Charging Co
5.38%
-1.81%
-5.00%
193.20M
Industrials
Merck & Company
3.63%
+0.42%
-0.98%
275.08B
Healthcare
Based on the activity of 759,782 active portfolios
Open your Smart Portfolio

AKRO Investor Analysis

AKRO investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
9.5%
of AKRO holders
are under 35
Average Segment Performance
Average P/E Ratio22.25
Beta8.29
Dividend Yield3.40%
AKRO investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
51.4%
of AKRO holders
are between 35–55
Average Segment Performance
Average P/E Ratio20.30
Beta14.63
Dividend Yield3.12%
AKRO investors over 55

Over 55

3.6%
Last 30 days
Holdings Change
39.2%
of AKRO holders
are over 55
Average Segment Performance
Average P/E Ratio21.78
Beta7.19
Dividend Yield3.21%
Overview of age group and performance of AKRO stock investors
See who invests in AKRO according to age group and performance.

FAQ

How many retail Investors hold AKRO?
<0.1% of TipRanks' retail investors hold AKRO in their portfolios.
    What is AKRO Investor Sentiment?
    AKRO’s Investor Sentiment is Negative.
      What percentage of retail investors changed their holding of AKRO in the last 7 days?
      ▲ 0.6% of TipRanks' retail investors changed their holding of AKRO in the last 7 days.
        What percentage of retail investors changed their holding of AKRO in the last 30 days?
        ▼ 1.6% of TipRanks' retail investors changed their holding of AKRO in the last 30 days.
          What is the average age of retail investors who hold AKRO?
          The average age of AKRO Holders is between 35–55.
            What other stocks have AKRO investors also bought?
            AKRO Investors also bought VKTX, JD, DKNG, ABT, BMY, SQ, PLUG, ENPH, BLNK, MRK.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              ACADACADIA Pharmaceuticals
              AAgilent
              BAXBaxter International
              BDXBecton Dickinson
              BMRNBioMarin Pharmaceutical
              What am I Missing?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis